Fig. 2From: Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort studyThe cumulative survival probability for the occurrence of opportunistic infections among paediatrics exposed to ABC versus AZT in Jimma medical centre, from April 10–May 10, 2017Back to article page